Colonic healing after early intraperitoneal administration of 5-fluorouracil and interferon in rats. 1997

I Kanellos, and C Odisseos, and T Zaraboukas, and A Kavouni, and K Galovatsea, and I Dadoukis
IV Department of Surgery, Aristotelian University of Thessaloniki, Greece.

The aim of this experimental study was to investigate whether the intraperitoneal perioperative injection of 5-flurouracil (5-FU)--with or without the addition of interferon (INT)--influences colonic healing. We used 57 male Wistar rats which were subjected to anastomosis of the colon. Intraoperatively, the rats were randomised into one of three groups. The rats in the control group (group 1, n = 15) received a 0.9% NaCl solution; the rats in group 2 (n = 21), 5-FU (20 mg/Kg/day), and those in group 3 (n = 21), 5-FU (20 mg/Kg/day) plus INT (45,000 IU/Kg/day). These drugs were injected intraperitoneally during the operation and once daily for the next two days. The rats were sacrificed on post-operative days 3, 5 or 8. The rupture rate of the anastomoses was statistically significantly higher in groups 2 and 3, compared with the control group (P < 0.05); no differences were observed between groups 2 and 3. Abscess and adhesion formation were more marked in groups 2 and 3 than in the control group; however no differences were recorded between groups 2 and 3. The anastomotic bursting pressure was statistically significantly lower in groups 2 and 3 compared to the control group (P < 0.05), on post-operative days 5 and 8; however, no differences were measured between groups 2 and 3. Histologic evaluation also showed a more profound inflammatory response in groups 2 and 3, compared with group 1. In conclusion, the intraperitoneal, intraoperative administration of 5-FU hinders colonic healing in rats. The additional intraperitoneal injection of interferon does not seem to aggravate this adverse effect.

UI MeSH Term Description Entries
D007274 Injections, Intraperitoneal Forceful administration into the peritoneal cavity of liquid medication, nutrient, or other fluid through a hollow needle piercing the abdominal wall. Intraperitoneal Injections,Injection, Intraperitoneal,Intraperitoneal Injection
D007372 Interferons Proteins secreted by vertebrate cells in response to a wide variety of inducers. They confer resistance against many different viruses, inhibit proliferation of normal and malignant cells, impede multiplication of intracellular parasites, enhance macrophage and granulocyte phagocytosis, augment natural killer cell activity, and show several other immunomodulatory functions. Interferon
D008297 Male Males
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D003106 Colon The segment of LARGE INTESTINE between the CECUM and the RECTUM. It includes the ASCENDING COLON; the TRANSVERSE COLON; the DESCENDING COLON; and the SIGMOID COLON. Appendix Epiploica,Taenia Coli,Omental Appendices,Omental Appendix,Appendices, Omental,Appendix, Omental
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005472 Fluorouracil A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid. 5-FU,5-FU Lederle,5-FU Medac,5-Fluorouracil,5-Fluorouracil-Biosyn,5-HU Hexal,5FU,Adrucil,Carac,Efudex,Efudix,Fluoro-Uracile ICN,Fluoroplex,Fluorouracil Mononitrate,Fluorouracil Monopotassium Salt,Fluorouracil Monosodium Salt,Fluorouracil Potassium Salt,Fluorouracil-GRY,Fluorouracile Dakota,Fluorouracilo Ferrer Far,Fluoruracil,Fluracedyl,Flurodex,Haemato-FU,Neofluor,Onkofluor,Ribofluor,5 FU Lederle,5 FU Medac,5 Fluorouracil,5 Fluorouracil Biosyn,5 HU Hexal,Dakota, Fluorouracile,Fluoro Uracile ICN,Fluorouracil GRY,Haemato FU
D000714 Anastomosis, Surgical Surgical union or shunt between ducts, tubes or vessels. It may be end-to-end, end-to-side, side-to-end, or side-to-side. Surgical Anastomosis,Anastomoses, Surgical,Surgical Anastomoses

Related Publications

I Kanellos, and C Odisseos, and T Zaraboukas, and A Kavouni, and K Galovatsea, and I Dadoukis
May 2007, Diseases of the colon and rectum,
I Kanellos, and C Odisseos, and T Zaraboukas, and A Kavouni, and K Galovatsea, and I Dadoukis
January 1998, European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes,
I Kanellos, and C Odisseos, and T Zaraboukas, and A Kavouni, and K Galovatsea, and I Dadoukis
February 1988, The Journal of surgical research,
I Kanellos, and C Odisseos, and T Zaraboukas, and A Kavouni, and K Galovatsea, and I Dadoukis
October 1997, Gan to kagaku ryoho. Cancer & chemotherapy,
I Kanellos, and C Odisseos, and T Zaraboukas, and A Kavouni, and K Galovatsea, and I Dadoukis
April 2004, Diseases of the colon and rectum,
I Kanellos, and C Odisseos, and T Zaraboukas, and A Kavouni, and K Galovatsea, and I Dadoukis
December 2008, International journal of colorectal disease,
I Kanellos, and C Odisseos, and T Zaraboukas, and A Kavouni, and K Galovatsea, and I Dadoukis
October 2001, International journal of cancer,
I Kanellos, and C Odisseos, and T Zaraboukas, and A Kavouni, and K Galovatsea, and I Dadoukis
May 1998, Diseases of the colon and rectum,
I Kanellos, and C Odisseos, and T Zaraboukas, and A Kavouni, and K Galovatsea, and I Dadoukis
January 1992, Journal de pharmacie de Belgique,
I Kanellos, and C Odisseos, and T Zaraboukas, and A Kavouni, and K Galovatsea, and I Dadoukis
January 2001, European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes,
Copied contents to your clipboard!